In this study, we examined an expanded panel of ccRCC cell lines and genetically manipulated TP53 in ccRCC cells to address whether p53 status is, indeed, an important determinant of HIF2 dependence and hence sensitivity to pharmacological HIF2 inhibitors. Here, TP53 is linked to nonpapillary renal cell carcinoma.